OG
Oren Gilad
Co-Founder, CEO, President & DirectorDr. Oren Gilad, Ph.D. is Co-Founder of Aprea Therapeutics, Inc (formerly known as Atrin Pharmaceuticals LLC) since 2011 and serves as its Chief Executive Officer since July 2022. Dr. Gilad serves as President and Director since May 2022 at Aprea Therapeutics, Inc. He serves as President and Director at Aprea Therapeutics AB since May 2022 and CEO since August 2022. Dr. Gilad earned his doctorate from the University of California at Davis and his B.S. from the Hebrew University, Jerusalem, Israel.
Positions
- Company NameAprea Therapeutics, Inc.Stock CodeAPREPositionCo-Founder, CEO, President & DirectorColleagues
- RPRichard PetersIndependent Chairperson of the Board
- JPJohn P. HamillSenior VP, CFO, Principal Accounting Officer & Secretary
- LBLars B. AbrahmsenSenior VP & Chief Scientific Officer
- BWBrian WileySenior Vice President of Corporate Development & Strategy
- MAMichel AfarganHead of Pharmacology Development
- MJMichael J. GrissingerIndependent Director
- JBJohn B. HennemanIndependent Director
- RPRifat PamukcuIndependent Director
